• Equity PC Ratio   0.57
  • |
  • Index PC Ratio   1.14
  • |
  • Total PC Ratio   0.97
  • |
  • VIX PC Ratio   0.54
  • VIX 14.25
  • VXN 17.82
  • VXO 15.25
  • ISEE 85.00

TruCharts Trading Strategies and Stock Buy/Sell Reports
(Show Details)


Chart Settings
No saved settings found!

Chart Type:
From: / / To: / /
Show detail in :
 Chart Skins:      
Price Overlays:





Indicator Windows:





Company Profile

Pfizer Inc., a biopharmaceutical company, engages in the discovery, development, manufacture, and marketing of prescription medicines for humans and animals worldwide. The company?s Biopharmaceutical segment offers products in the areas of primary care, specialty care, established products, emerging markets, and oncology customer-focused units. Its principal products include Lipitor for elevated cholesterol levels in the blood; Norvasc for hypertension; Caduet for cardiovascular events; Chantix/Champix for smoking cessation; Lyrica for neuropathic pain; Revatio for pulmonary arterial hypertension; Geodon/Zeldox, a psychotropic agent; and Aricept for Alzheimer?s disease. This segment?s products also comprise Celebrex for osteoarthritis and rheumatoid arthritis and acute pain; Zyvox for Gram-positive pathogens; Viagra for erectile dysfunction; Detrol/ Detrol LA for overactive bladder; Sutent for advanced renal cell carcinoma; Xalatan for open-angle glaucoma and ocular hypertension; Genotropin for growth disorders; Vfend, an antifungal agent; Effexor for depressive disorders; Prevnar/Prevnar7 for invasive pneumococcal disease; Enbrel for rheumatoid arthritis; Protonix, proton pump inhibitor for erosive esophagitis; and Spiriva for breathing problems. The company?s Diversified segment offers animal health products, which include antibiotics, anti-inflammatories, antiemetics, parasiticides, and vaccines; consumer healthcare products comprising dietary supplements, pain management, respiratory, and topicals/gastro-intestinal products; Nutrition products; and Capsugel products that include gelatin, liquid, softgel, non-animal, and fish gelatin capsules. Pfizer Inc. serves doctors, nurse practitioners, physician assistants, pharmacists, hospitals, pharmacy benefit managers, managed care organizations, and government agencies. It has a strategic alliance with Acacia Living Inc. The company was founded in 1849 and is headquartered in New York, New York.

YES
     
PFE (Pfizer Inc)
Last Trade 36.46 Date 10/18/2019
Change % 0.00 % Price Change 0.00
Open 36.43 52 Week High 46.47
High 36.7 52 Week Low 33.97
Low 36.35 Type stock
Volume 13491206 Average Volume 23751678
Prev Close 36.46 Stock Exchange NYSE
Bid 36.38 Ask 36.7
Bid Size 5 Ask Size 1
1st Yr Estimated EPS Growth 0.0122 2nd Yr Estimated EPS Growth 0.0565
2 Years Forward Earning Yield 0.0836 2 Years Forward PE Ratio 11.9619
2 Years EV/Forward EBIT 11.7254 2 Years EV/Forward EBITDA 10.2251
Book Value per Share 10.7665 Book Value Yield 0.2953
Buy Back Yield 0.0744 CAPE Ratio 21.014
Cash Return 0.0555 Cash Flow per Share 2.4536
Cash Flow Yield 0.0673 Dividend Rate 1.44
Dividend Yield 3.89 5 Year Dividend Yield 0.0345
Earning Yield 0.0598 EV/EBIT 17.9384
EV/EBITDA 12.1031 EV / Free Cash Flow 20.0444
EV / Forward EBIT 12.8379 EV / Forward EBITDA 10.6551
EV / Forward Revenue 4.5819 EV / Pre Tax Income 20.1336
EV / Revenue 4.388 EV / Total Asset 1.5073
Expected Dividend Growth Rate 0.0141 Free Cash Flow per Share 2.0146
Free Caash Flow Ratio 18.098078 Free Cash Flow Yield 0.0553
Forward Calculation Style Annual Forward Dividend Yield 0.0395
Forward Earning Yield 0.0791 Forward PE Ratio 12.6422
Forward Return on Asset 0.1022 Forward Return on Equity 0.268
Normalized PE Ratio 12.792529 Payout Ratio 0.6422
PB Ratio 3.386432 PB Ratio 10 Year Growth 0.064379
PB Ratio 3 Year Growth 3.414976 Cash Ratio 3 Year Average 1464.6651
Price to Cash Flow Ratio 14.859502 PEG Payback 9.1053
PEG Ratio 2.6219 PE Ratio 16.724771
PE Ratio 10 Year Average 20.394102 PE Ratio 10 Year Growth 0.011398
PE Ratio 10 Year High 33.61 PE Ratio 10 Year Low 9.553977
PE Ratio 1 Year Avg 17.871298 PE Ratio 1 Year High 23.311828
PE Ratio 1 Year Low 10.007595 PE Ratio 3 Year Avg 20.104557
PE Ratio 5 Year Avg 22.0796 PE Ratio 5 Year High 33.61
PE Ratio 5 Year Low 9.553977 Free Cash Flow Ratio 10 Year Growth 0.095821
Free Cash Flow Ratio 3 Year Avg 16.35479 Price Change 1 Month 1.014751
Price to Cash Ratio 15.618186 Price / EBITDA 10.927879
Price to Sales Ratio 3.961906 Price to Sales Ratio 10 Year Growth 0.042213
Price to Sales Ratio 3 Year Avg 4.247646 Price to Sales Ratio 5 Year Avg 22.0796
Sale per Share 9.2026 Sales Yield 0.2524
Sustainable Growth Rate 0.07 Tangible Book Value per Share -4.8503
Tangible Book Value per Share 3 year Avg -6.8328 Tangible Book Value per Share 5 year Avg -4.9036
Total Asset per Share 28.2404 Total Yield 0.1133
Working Capital per Share 2.7197 Working Capital per Share 3 Year Avg 1.6115
Working Capital per Share 5 Year Avg 2.701 Beta 0.422969